Efficacy and Safety of a New Sperm Capacitation Method

Launched by FECUNDIS LAB SL · Dec 16, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new method called HyperSperm, which aims to help improve sperm quality for men experiencing reproductive issues, such as low sperm count or poor sperm movement. Over a year, researchers will study semen samples from 300 men to see how effective and safe this method is, without any medical treatment being given during the process.

To be part of this study, men aged between 18 and 50 must be able to provide a semen sample through masturbation. However, those with certain health issues, like sexually transmitted infections or a history of hepatitis or HIV, cannot participate. If you join the study, you'll be helping scientists understand better ways to support men facing infertility challenges, and you'll be contributing valuable information that could lead to improved treatments in the future.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Ability to provide a semen sample via masturbation
• Exclusion Criteria:
• • Current diagnosis of a sexually transmitted infection (STI)
• • Previous diagnosis of hepatitis A, B, C, D, or HIV
• • Prior participation in this study
• • Participation in a clinical trial involving an intervention within the last 3 months